DRKS00005940已完成不适用
Early MOnitoring of REsponse on the therapy of Golimumab (GLM) with fecal calprotectin and trough serum levels in patients with ulcerative colitis. A multicentric, prospective study - MORE
GISG Organisationsbüro Kompetenznetz Darmerkrankungen0 个研究点目标入组 61 人开始时间: 2014年9月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 61
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Established diagnosis of ulcerative colitis by endoscopical and clinical determination
- •2. Trial-independend treatment with golimumab according to routine local prescribing practice at the discretion of the investigator
- •3. Minimum age of 18 years
- •4. The patient must be capable in communicating sufficiently in German
- •5. The patient must be able to recognize the nature, significance and scope of the study and must agree in a written informed consent.
- •6. Increased level of calprotectin (=100 mg/l or =100 mg/kg) within 3 weeks prior to inclusion or existing endoscopic record of a distinct inflammatory response (UCEIS = 3 points).
排除标准
- •1. Infectious colitis
- •2. Treatment with Golimumab outside the label
- •3. Treatment with Golimumab within the last 3 month
研究者
相似试验
进行中（未招募）
1 期
Response monitoring with special chemotherapie (monoclonal antibody) in metastatic colorectal cancermetastatic colorectal cancerMedDRA version: 16.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864EUCTR2009-013279-23-DEniversity Hospital of Heidelberg35
已完成
不适用
In vivo response monitoring of treatment with the epidermal growth factor receptor (EGFR) monoclonal antibody cetuximab in metastatic colorectal cancerMetastatic colorectal cancerMalignant neoplasm of rectosigmoid junctionCancerISRCTN75334801niversity of Heidelberg (Germany)35
已完成
3 期
Study to learn whether Gudathailika Basti is effective in Gridhrasi - low back pain radiating to legsCTRI/2019/04/018739Sambhu20
招募中
2 期
An exploratory study for therapeutic effects of geranylgeranylacetone on heart failureheart failureJPRN-jRCTs031220395Akasaka Takeshi160
已完成
不适用
Early evaluation of therapy response (targeted therapy and immunotherapy) in patients with metastasized malignant melanoma by multiparametric PET/MR imaging.C43.9Malignant melanoma of skin, unspecifiedDRKS00013925niversitätsklinikum Tübingen, Radiologische Klinik, Diagnostische & Interventionelle Radiologie62